Object. The goal of this study was to determine racial/ethnic differences in inpatient mortality rates and the use of institutional postacute care following subarachnoid hemorrhage (SAH) in the US.
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S ubarachnoid hemorrhage (SAH) causes disproportionately higher rates of death and disability compared with other stroke subtypes. 10 Epidemiological studies have demonstrated racial/ethnic differences in SAH incidence and mortality in the US. African-Americans, 1, 4, [14] [15] [16] 24 Asian/Pacific Islanders (APIs), 1, 21, 24 and Hispanics 1, 6, 8, 16, 24 have been shown to have higher incidences of and mortality rates from SAH compared with the white population. However, only a few studies have examined differences in outcomes among racial/ethnic groups, while simultaneously accounting for factors that could potentially confound the race/ethnicity association with mortality. These studies have done so using patients participating in trials 23 or patients in a small geographic cohort. 9, 30 Furthermore, the study populations were more commonly recruited prior to significant paradigm changes in treatment practice, which has significantly impacted case fatality. Moreover, these studies have reported conflicting results. For instance, one post hoc analysis predominantly compared African-Americans to Caucasians who were reRacial/ethnic differences in inpatient mortality and use of institutional postacute care following subarachnoid hemorrhage cruited into a large clinical trial between 1991 and 1997 and did not find any significant race/ethnic differences in 3-month functional outcome. 23 Another study based on the New York database of hospital discharges in 2003 reported that white patients in New York with SAH had better functional outcomes than nonwhite patients. 30 It is presently unknown whether the use of institutional care among survivors of SAH differs across racial/ethnic groups. This study was therefore conducted to determine first whether racial/ ethnic groups differ in the risk of in-hospital mortality, and second whether racial/ethnic differences are present in the use of institutional postacute care following hospitalization for SAH.
Methods

Patient Population
The patient sample for this study was obtained from the Nationwide Inpatient Sample (NIS), Healthcare Cost and Utilization Project (HCUP), Agency for Healthcare Research and Quality, Rockville, Maryland. This database archives nationally representative data on inpatient stays at acute-care hospitals in the US and contains relevant demographic, diagnostic, procedure, and hospital information. We used data for the years 2005-2010 to analyze a cohort that would be most reflective of current treatment practices in SAH. Patients with SAH were identified using the appropriate ICD-9-CM diagnostic code (430) related to the principal diagnosis. To minimize including patients who may have traumatic SAH, the abstracted data set was further screened for secondary diagnoses related to head trauma (ICD-9-CM codes 800.0-801.9, 803.0-804.9, 850.0-854.1, or 873.0-873.9). The study was approved by the research ethics board at St. Michael's Hospital.
Variables Analyzed
The independent variable was patient self-identified race/ethnicity, categorized in the NIS as white, black, Hispanic, API, Native American, or other. A number of covariates that could help explain or confound the effect of race/ethnicity on the outcomes of interest were accounted for in the analysis. These were patient age; sex; neighborhood median income according to patient zip code (expressed in quartiles-a measure of socioeconomic status at the community level); insurance status (categorized as Medicare, Medicaid, private including health maintenance organization [HMO], self-pay, or no charges); admission type (elective, urgent, or emergency); hospital region (Northeast, Midwest, South, or West); bed size (small, medium, or large); and hospital teaching status (nonteaching or teaching). To account for the effect of comorbid conditions, we computed each patient's Charlson Comorbidity Index (CCI) score according to the modification proposed by Deyo et al.; 7 this is a weighted summary score based on the presence or absence of 17 medical conditions. We further categorized CCI into 4 groups, including CCIs of 1, 2, 3, or ≥ 4. The primary outcome was in-hospital mortality, whereas the secondary outcome was discharge to institutional care (defined as transfer to a short-term hospital); other transfer (including skilled nursing facility, intermediate care, and another type of facility); and home health care.
Handling of Missing Data
The proportion of missing data was less than 0.5% for most variables except for admission type (23.8%), neighborhood median income quartile (2.4%), and race (23.9%). We set admission type to "emergency" if admission source was the emergency room; to "urgent" if admission source was from another hospital, including admissions from long-term facilities; and to "routine" if admission source was coded as "routine" in the NIS. This technique has been used previously. 12 Multiple imputation was performed for all missing values of neighborhood income and race by using chained equations to generate 20 imputed data sets for analysis. 27 The imputation model consisted of our predictor variable, explanatory variables, and outcome variable as well as weighting for discharge and hospital data provided for variance estimation.
Statistical Analysis
Patient demographic and clinical and hospital characteristics were summarized according to race/ethnicity by using descriptive statistics, with continuous variables expressed as the mean ± SD and categorical variables expressed as frequencies (percentage). Differences among racial/ethnic groups for categorical variables were tested with a Mantel-Haenszel chi-square test, and for continuous variables differences were tested using ANOVA. The associations between race/ethnicity and patient discharge disposition were examined by fitting multinomial logistic regression models, adjusting for the aforementioned explanatory variables. The baseline outcome was routine discharge or discharged alive, destination unknown. In all analyses we accounted for the single-stage stratified cluster sampling design of the NIS by applying weighting for the discharge and hospital data provided in the NIS for accurate variance estimation, by using the Stata "svyset" suite of commands. This also allowed for extrapolation of results to the entire US population.
The level of statistical significance was set at p ≤ 0.05. All analyses were repeated using complete cases only and gave similar results. All data analyses were performed with Stata version 12.1 (Stata Corp.).
Results
During the study period, 31,631 discharges were recorded in the NIS for SAH. Table 1 shows baseline characteristics of the study cohort by race/ethnicity. White and API patients were significantly older than patients in other ethnic groups (p ≤ 0.001). Patients in the Hispanic group were less likely to be female compared with other groups. Black patients were more likely to live in lowincome neighborhoods, whereas API patients were more likely to live in high-income neighborhoods. The crude in-hospital mortality rate was 22%, and the proportion of patients discharged to institutional care was 42%.
In multivariable analyses, race/ethnicity was a signif-icant predictor of in-hospital mortality (p = 0.003) and of discharge to institutional care (p ≤ 0.001). Black patients were similar to white patients in the risk of in-hospital mortality (OR 1.04, 95% CI 0.93-1.16), but were more likely to be discharged to postacute institutional care than white patients (OR 1.27, 95% CI 1.14-1.40) ( American patients were at higher risk of death (OR 1.10, 95% CI 0.90-1.34) and institutional care (OR 1.16, 95% CI 0.98-1.38), although the differences were not statistically significant (Table 2 ). Figure 1 shows a plot of racial/ ethnic differences in the risk of in-hospital mortality by age, expressed as predicted probabilities. Hispanic patients were the least likely to die during hospitalization, whereas API patients were the most likely to die during hospitalization for SAH.
Discussion
Among patients with SAH admitted to acute-care hospitals in the US, race/ethnicity was a significant predictor of inpatient mortality and discharge to institutional care. Racial/ethnic differences were present after accounting for age, sex, socioeconomic and insurance status, and other clinical and hospital characteristics that could potentially influence outcomes. The results of this study agree to some extent with those of a study of the New York SPARC (Statewide Planning and Research Cooperative System) database that suggested that white patients with SAH had better functional outcomes than nonwhite patients. 30 Our findings, however, are different from those of other hospital- 15, 21, 23 and population-based studies 9, 29 in the US 9, 15, 21, 23 and other countries 29 that demonstrated no racial/ethnic differences in case fatality rate, 15, 21 functional disability, 21 or other outcomes. 9, 29 The small number of events observed in previous studies, 21 especially with respect to groups other than "Whites" or "Blacks,"
23,29 may well have contributed to the negative findings of these studies. It is also plausible that differences in the categorization of race/ethnicity in the different studies contributed to the inconsistency between our findings and those of prior studies.
Our analysis showed that black and white patients had a similar risk of death. Previous studies also showed that, after adjustment for important determinants of outcome, these groups do not differ significantly in survival rates, case fatality rate, 15 time to treatment, 9 or 3-month functional outcome. 23 Taken together, these findings indicate that black and white patients have a comparable short-term prognosis after SAH. Although in the present study black patients were more likely to be discharged to other facilities rather than to home, whether this result indicates greater residual disability in black patients or is due to the presence of other factors related to referral to or receipt of postacute institutional care can only be a matter of speculation.
Our finding of significantly lower risk of in-hospital mortality in patients of Hispanic ethnicity compared with non-Hispanic white patients agrees with a growing body of epidemiological literature in the US; this literature shows that Hispanic ethnicity is associated with lower risk of all-cause and disease-specific death. 3, 5, 13, 17, 28 The estimated relative risk reduction of 16% in this study is comparable to the 7%-13% reported for stroke patients of Hispanic ethnicity in the population-based Brain Attack Surveillance in the Corpus Christi Project in Texas.
17
In the Northern Manhattan Study (NOMAS), 28 Hispanic ethnicity was associated with much greater risk reduction for coronary death (64%) and vascular death (34%). Hispanic populations in the US on average have a lower socioeconomic status, greater burden of risk factors, lower insurance coverage, and lower access to the processes of care than do non-Hispanic white patients. 19 By experiencing more favorable mortality outcomes than non-Hispanic white patients, Hispanic patients present an "epidemiologic paradox," the cause of which, although the subject of ongoing investigations, remains uncertain.
3,28
Of the racial/ethnic groups compared in this study, API patients had the highest risk of death and need for postacute institutional care. A somewhat different result was reported by a similar study that used only the 1997 NIS data and found that API patients were similar to nonHispanic white patients in the risk of in-hospital mortality but had more need for postacute institutional care than did non-Hispanic white patients. However, among patients who received thrombolysis for acute ische mic stroke in the US, API patients had the highest risk of death and intracerebral hemorrhage. 2, 20 The prospective, population-based Auckland Regional Community Stroke III study in New Zealand also found that API patients had the worst 6-month functional outcomes after acute ischemic stroke compared with other racial/ethnic groups. 18 A number of reasons may explain the worse prognosis in API patients. It is possible these patients have more severe SAH. Secondly, some studies have reported that API patients have a relatively low likelihood of admission to high-quality hospitals after stroke, compared with other racial/ethnic groups in the US. 25 Timely, quality, specialized care has been identified as critical to improved outcomes after SAH. 26 Furthermore, researchers have reported cultural, language, and other barriers among Asian Americans that could have a significant impact on their capacity to access health care and experience favorable health outcomes. 22 Nevertheless, these explanations do not account for the fact that API patients in the US constitute a heterogeneous group reflecting to a larger extent than other racial/ethnic groups both extremes of socioeconomic status. For instance, API patients in the present study lived in wealthier neighborhoods relative to other racial/ethnic groups.
Study Limitations
This study has a number of limitations that could impact its conclusions. First, because the study is not population based, the results do not apply to the 15% or so of patients with SAH who do not survive to receive treatment in acute-care hospitals. Second, because of its cross-sectional design, the findings should be interpreted with caution for long-term mortality and morbidity outcomes. Third, the categorization of race/ethnicity, as it is done in the NIS, is a social construct that is not based on any unique genetic composition; hence, the results of this study may not necessarily be due to genetic differences among studied groups. Fourth, because the NIS has no variable to measure SAH severity, we did not adjust for this important prognostic factor and hence could not ascertain whether controlling for SAH severity could have attenuated the observed racial/ethnic differences. Last, because some states do not submit information on race to the NIS, this information was missing for 20% of discharges and we resorted to multiple imputation to minimize loss of data points.
Although this approach is considered better than a complete case analysis, it does not completely eliminate the inherent bias due to missing data on race.
11 Despite these limitations, this study used a very large sample size, far exceeding those of any previous studies, which makes any insignificant results not due to a lack of statistical power. The nationwide data also enhance the generalizability of the results. Furthermore, the findings are more applicable to a contemporary context because the cohort is more reflective of current treatment practices in SAH than were the cohorts in previous studies.
Conclusions
This study found that patients with SAH who survived to receive treatment in hospitals differed significantly in their risk of in-hospital mortality and use of institutional postacute care when compared according to their self-reported racial/ethnic groups. The study indicated Hispanic patients have the best outcomes and that API patients have the worst outcomes during the inpatient course. The reasons for these prognostic disparities deserve further research because they appear to be important in improving outcomes in identified high-risk groups.
